Trade Summary

3 days ago, Boughton Soleil, serving as Chief Legal Officer at Hims & Hers Health, Inc. (HIMS), sold 25,111 shares at $27.55 per share, for a total transaction value of $691,808.05. Following this transaction, Boughton Soleil now holds 313,964 shares of HIMS.

This sale represents a 7.41% decrease in Boughton Soleil's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 4:30 PM ET, 1 day after the trade was made.

Hims & Hers Health, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.